Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Effect of Panretinal Photocoagulation on Optic Nerve Head Topography (PRP)
This study is not yet open for participant recruitment.
Verified by University of Nebraska, October 2008
Sponsored by: University of Nebraska
Information provided by: University of Nebraska
ClinicalTrials.gov Identifier: NCT00767884
  Purpose

The purpose of this study is to evaluate the optic nerve head changes consequent to panretinal photocoagulation done for diabetic retinopathy.


Condition
Diabetic Retinopathy

MedlinePlus related topics: Diabetic Eye Problems Retinal Disorders
U.S. FDA Resources
Study Type: Observational
Official Title: Effect of Panretinal Photocoagulation on Optic Nerve Head Topography and Nerve Fiber Layer Parameters

Further study details as provided by University of Nebraska:

Estimated Enrollment: 30
Study Start Date: October 2008
Estimated Study Completion Date: October 2009
Estimated Primary Completion Date: October 2009 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   19 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Ophthalmology Clinic at UNMC

Criteria

Inclusion Criteria:

  • Any patient with proliferative diabetic retinopathy or severe non-proliferative diabetic retinopathy otherwise undergoing panretinal photocoagulation for treatment.

Exclusion Criteria:

  • Any patient with uncontrolled glaucoma (IOP above target on any occasion in the preceding 6 months) or other optic neuropathy that may confound the analysis of optic nerve head morphology.
  • Patients with media opacities (significant cataract, corneal opacity, vitreous hemorrhage) precluding imaging of the optic nerve.
  • No PRP done in the previous 6 months.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00767884

Contacts
Contact: Vikas Gulati, MD 402-559-4276 vgulati@unmc.edu
Contact: Carl Camras, MD 402-559-4276 cbcamras@unmc.edu

Locations
United States, Nebraska
University of Nebraska Medical Center Eye Clinic
Omaha, Nebraska, United States, 68198-5540
Sponsors and Collaborators
University of Nebraska
Investigators
Principal Investigator: Vikas Gulati, MD UNMC
  More Information

Responsible Party: UNMC Department of Ophthalmology ( Vikas Gulati )
Study ID Numbers: 413-08-EP
Study First Received: October 3, 2008
Last Updated: October 6, 2008
ClinicalTrials.gov Identifier: NCT00767884  
Health Authority: United States: Institutional Review Board

Keywords provided by University of Nebraska:
panretinal photocoagulation
diabetic retinopathy
optic nerve head changes

Study placed in the following topic categories:
Diabetic Retinopathy
Eye Diseases
Diabetes Mellitus
Vascular Diseases
Endocrine System Diseases
Endocrinopathy
Diabetes Complications
Retinal Diseases
Diabetic Angiopathies

Additional relevant MeSH terms:
Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 16, 2009